6JPA image
Deposition Date 2019-03-26
Release Date 2019-06-12
Last Version Date 2024-11-13
Entry Detail
PDB ID:
6JPA
Title:
Rabbit Cav1.1-Verapamil Complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit alpha-1S
Gene (Uniprot):CACNA1S
Chain IDs:A
Chain Length:1506
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit beta-1
Gene (Uniprot):CACNB1
Chain IDs:C (auth: B)
Chain Length:450
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit beta-1
Gene (Uniprot):CACNB1
Chain IDs:D (auth: C)
Chain Length:524
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel gamma-1 subunit
Gene (Uniprot):CACNG1
Chain IDs:B (auth: E)
Chain Length:222
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel subunit alpha-2/delta-1
Gene (Uniprot):CACNA2D1
Chain IDs:E (auth: F)
Chain Length:1046
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Primary Citation
Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+Channel.
Cell 177 1495 1506.e12 (2019)
PMID: 31150622 DOI: 10.1016/j.cell.2019.04.043

Abstact

The L-type voltage-gated Ca2+ (Cav) channels are modulated by various compounds exemplified by 1,4-dihydropyridines (DHP), benzothiazepines (BTZ), and phenylalkylamines (PAA), many of which have been used for characterizing channel properties and for treatment of hypertension and other disorders. Here, we report the cryoelectron microscopy (cryo-EM) structures of Cav1.1 in complex with archetypal antagonistic drugs, nifedipine, diltiazem, and verapamil, at resolutions of 2.9 Å, 3.0 Å, and 2.7 Å, respectively, and with a DHP agonist Bay K 8644 at 2.8 Å. Diltiazem and verapamil traverse the central cavity of the pore domain, directly blocking ion permeation. Although nifedipine and Bay K 8644 occupy the same fenestration site at the interface of repeats III and IV, the coordination details support previous functional observations that Bay K 8644 is less favored in the inactivated state. These structures elucidate the modes of action of different Cav ligands and establish a framework for structure-guided drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures